Select a Region
North America

Browsing Archive: ArticleArticle | EVERSANA - Part 10

EVERSANA
Posted on February 1, 20232/1/23

Meta-analysis of proptosis response in thyroid eye disease: Efficacy of EUGOGO recommended treatment regimen with IV methylprednisolone

EVERSANA
Posted on February 1, 20232/1/23

Ozanimod for induction treatment of moderate-to-severe ulcerative colitis: results from a systematic literature review and network meta-analyses

EVERSANA
Posted on February 1, 20232/1/23

Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis

EVERSANA
Posted on February 1, 20232/1/23

Indirect treatment comparison of Liso-Cel vs. salvage chemotherapy in diffuse large B-cell lymphoma: TRANSCEND vs. SCHOLAR-1

EVERSANA
Posted on February 1, 20232/1/23

Health impact of tafmidis in transthyretin amyloid cardiomyopathy patients: an analysis from the tafamidis in transthyretic cardiomyopathy clinical trial (ATTR-ACT) and the open-label long-term extension studies

EVERSANA
Posted on February 1, 20232/1/23

Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors

EVERSANA
Posted on February 1, 20232/1/23

CDK4/6 Inhibitors in HR+/HER2- Advanced/Metastatic Breast Cancer: A Systematic Literature Review of Real-World Evidence Studies.

EVERSANA
Posted on February 1, 20232/1/23

Risk of recurrence among patients with HR-positive, HER2-negative, early breast cancer receiving adjuvant endocrine therapy: A systematic review and meta-analysis

EVERSANA
Posted on February 1, 20232/1/23

Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer

EVERSANA
Posted on February 1, 20232/1/23

Meta-Analysis of Proptosis Response in Thyroid Eye Disease: Efficacy of EUGOGO Recommended Treatment Regimen With IV Methylprednisolone

Article